These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31785780)

  • 21. Cutting Edge Genetics: CRISPR/Cas9 Editing of Plant Genomes.
    Soyars CL; Peterson BA; Burr CA; Nimchuk ZL
    Plant Cell Physiol; 2018 Aug; 59(8):1608-1620. PubMed ID: 29912402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Applications of CRISPR/Cas System to Bacterial Metabolic Engineering.
    Cho S; Shin J; Cho BK
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29621180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRISPR-Cas9 technology and its application in haematological disorders.
    Zhang H; McCarty N
    Br J Haematol; 2016 Oct; 175(2):208-225. PubMed ID: 27619566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiplexed CRISPR/Cas9- and TAR-Mediated Promoter Engineering of Natural Product Biosynthetic Gene Clusters in Yeast.
    Kang HS; Charlop-Powers Z; Brady SF
    ACS Synth Biol; 2016 Sep; 5(9):1002-10. PubMed ID: 27197732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [CRISPR/Cas systems in genome engineering of bacteriophages].
    Liang CJ; Meng FM; Ai YC
    Yi Chuan; 2018 May; 40(5):378-389. PubMed ID: 29785946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CRISPR/Cas9 advances engineering of microbial cell factories.
    Jakočiūnas T; Jensen MK; Keasling JD
    Metab Eng; 2016 Mar; 34():44-59. PubMed ID: 26707540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Application of CRISPR/Cas9 mediated genome editing in farm animals].
    Xing YY; Yang Q; Ren J
    Yi Chuan; 2016 Mar; 38(3):217-26. PubMed ID: 27001476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRISPR-Cas9 Toolkit for Actinomycete Genome Editing.
    Tong Y; Robertsen HL; Blin K; Weber T; Lee SY
    Methods Mol Biol; 2018; 1671():163-184. PubMed ID: 29170959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current situation of biofuel production and its enhancement by CRISPR/Cas9-mediated genome engineering of microbial cells.
    Javed MR; Noman M; Shahid M; Ahmed T; Khurshid M; Rashid MH; Ismail M; Sadaf M; Khan F
    Microbiol Res; 2019 Feb; 219():1-11. PubMed ID: 30642460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel CRISPR-Cas Systems: An Updated Review of the Current Achievements, Applications, and Future Research Perspectives.
    Nidhi S; Anand U; Oleksak P; Tripathi P; Lal JA; Thomas G; Kuca K; Tripathi V
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted genome editing in the rare actinomycete Actinoplanes sp. SE50/110 by using the CRISPR/Cas9 System.
    Wolf T; Gren T; Thieme E; Wibberg D; Zemke T; Pühler A; Kalinowski J
    J Biotechnol; 2016 Aug; 231():122-128. PubMed ID: 27262504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [CRISPR-Cas systems as weapons against pathogenic bacteria].
    Bikard D; Barrangou R
    Biol Aujourdhui; 2017; 211(4):265-270. PubMed ID: 29956653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The New State of the Art: Cas9 for Gene Activation and Repression.
    La Russa MF; Qi LS
    Mol Cell Biol; 2015 Nov; 35(22):3800-9. PubMed ID: 26370509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plant Viruses: From Targets to Tools for CRISPR.
    Varanda CM; Félix MDR; Campos MD; Patanita M; Materatski P
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33478128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Gene networks that regulate secondary metabolism in actinomycetes: pleiotropic regulators].
    Rabyk MV; Ostash BO; Fedorenko VO
    Tsitol Genet; 2014; 48(1):67--82. PubMed ID: 24791475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CRISPR/Cas technology promotes the various application of Dunaliella salina system.
    Feng S; Hu L; Zhang Q; Zhang F; Du J; Liang G; Li A; Song G; Liu Y
    Appl Microbiol Biotechnol; 2020 Oct; 104(20):8621-8630. PubMed ID: 32918585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome Editing in Clostridium saccharoperbutylacetonicum N1-4 with the CRISPR-Cas9 System.
    Wang S; Dong S; Wang P; Tao Y; Wang Y
    Appl Environ Microbiol; 2017 May; 83(10):. PubMed ID: 28258147
    [No Abstract]   [Full Text] [Related]  

  • 39. CRISPR-Cas9 and CRISPR-Assisted Cytidine Deaminase Enable Precise and Efficient Genome Editing in Klebsiella pneumoniae.
    Wang Y; Wang S; Chen W; Song L; Zhang Y; Shen Z; Yu F; Li M; Ji Q
    Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30217854
    [No Abstract]   [Full Text] [Related]  

  • 40. [Changes of resistant phenotype and CRISPR/Cas system of four
    Zhang B; Hong LJ; Duan GC; Liang WJ; Yang HY; Xi YL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Feb; 38(2):235-239. PubMed ID: 28231673
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.